| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PD-0325901 | CCLE | pan-cancer | AAC | -0.11 | 0.01 |
| mRNA | Sorafenib | FIMM | pan-cancer | AAC | 0.5 | 0.01 |
| mRNA | NSC-207895 | GDSC1000 | pan-cancer | AAC | 0.085 | 0.01 |
| mRNA | CX-5461 | GDSC1000 | pan-cancer | AAC | 0.081 | 0.01 |
| mRNA | lenvatinib | CTRPv2 | pan-cancer | AAC | 0.1 | 0.01 |
| mRNA | CIL70 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.01 |
| mRNA | StemRegenin 1 | CTRPv2 | pan-cancer | AAC | 0.095 | 0.01 |
| mRNA | tandutinib | CTRPv2 | pan-cancer | AAC | 0.099 | 0.01 |
| mRNA | cediranib | CTRPv2 | pan-cancer | AAC | 0.15 | 0.01 |
| mRNA | Mdivi-1 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.01 |